Kehua Biology: Neisseria gonorrhoeae Nucleic Acid Detection Kit Obtains Medical Device Registration Certificate

Kehua Biological announced that it recently received the medical device registration certificate for the Neisseria gonorrhoeae nucleic acid testing kit issued by the National Medical Products Administration. The validity period of the registration certificate is from August 4, 2026, to August 3, 2031. This kit is used for the in vitro qualitative detection of Neisseria gonorrhoeae nucleic acid in male urethral swabs and female cervical swab samples. The acquisition of this new product registration certificate enriches the company's product line and has a positive impact on business development, but it is currently impossible to predict the impact on future revenue.